BUB — Bubs Australia Share News
0.000.00%
Last trade - 00:00- AU$81.37m
- AU$87.88m
- AU$111.86m
Bubs Australia shares set for 15% weekly gain on FDA approval for infant formula products
Bubs Australia extends rally after infant formulas get US FDA approval
Bubs Australia gets permanent FDA nod for infant formula sales in US, shares jump (updated)
Bubs Australia secures permanent FDA nod for infant formula sales in US, shares jump
Brief: Bubs Australia Secures Permanent Us FDA Approval For Infant Formula
Bubs Australia jumps 45% on FDA approval for infant formula products
Brief: Bubs Australia Posts FY EBITDA AUD -1.8 Million
Brief: Bubs Australia Expects FY26 Revenue Of A$105–115 Million
Brief: Bubs Australia Posts Q3 FY26 Net Revenue Up 10% To A$25.5 Million
Brief: Bubs Australia Posts H1 Adjusted EBITDA AUD 4.4 Million
Brief: Bubs Australia Says FDA Continues Review Of Bubs' Infant Formula Submissions
Brief: Bubs Australia Sees FY26 Revenue Of A$120-A$125 Million
Brief: Bubs Australia Says Co Expects To Recover A$825,000 From Secured Creditor Of Willis
Brief: Bubs Australia Posts Quarterly EBITDA Of A$0.5 Million
Bubs Australia falls on downbeat quarterly cashflow outlook
Polymetals Resources plunges after mine fatality
Bubs Australia gains on announcing leadership changes
Brief: Bubs Australia Appointed Joe Coote As Managing Director, CEO
Brief: Bubs Australia Says Katrina Rathie Steps Down As Independent Chair